🇺🇸 FDA
Patent

US 9434717

Solid forms of 3-(6-(1-(2,2-difluorobenzo[d][1,3]dioxol-5-yl)cyclopropanecarboxamido)-3-methylpyridin-2-yl) benzoic acid

granted A61KA61K31/4709A61P

Quick answer

US patent 9434717 (Solid forms of 3-(6-(1-(2,2-difluorobenzo[d][1,3]dioxol-5-yl)cyclopropanecarboxamido)-3-methylpyridin-2-yl) benzoic acid) held by Vertex Pharmaceuticals Incorporated expires Mon Sep 01 2036 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Vertex Pharmaceuticals Incorporated
Grant date
Tue Sep 06 2016 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Sep 01 2036 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
5
CPC classes
A61K, A61K31/4709, A61P, A61P1/18, A61P11/00